NAS:BLFS (USA) Also trade in: Germany

BioLife Solutions Inc

$ 17.53 0.56 (3.3%)
Volume: 155,383 Avg Vol (1m): 178,108
Market Cap $: 348.84 Mil Enterprise Value $: 317.05 Mil
P/E (TTM): 109.54 P/B: 9.60
Earnings Power Value 0.02
Net Current Asset Value 1.46
Tangible Book 1.82
Projected FCF 0.65
Median P/S Value 3.19
Graham Number 2.56
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 9.4/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 1178.67
Cash-To-Debt range over the past 10 years
Min: 0, Med: 10000, Max: 10000
Current: 1178.67
0
10000
Equity-to-Asset 0.92
Equity-to-Asset range over the past 10 years
Min: -7.3, Med: 0.53, Max: 0.95
Current: 0.92
-7.3
0.95
Debt-to-EBITDA 0.01
Debt-to-EBITDA range over the past 10 years
Min: -111.61, Med: -8.52, Max: 0.01
Current: 0.01
-111.61
0.01
Interest Coverage 703.67
Interest Coverage range over the past 10 years
Min: 703.67, Med: 5366.2, Max: 10000
Current: 703.67
703.67
10000
Piotroski F-Score 6
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 52.86
DISTRESS
GREY
SAFE
Beneish M-Score -0.54
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 46.36%
WACC 12.44%

Profitability & Growth : 3/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 19.46
Operating Margin range over the past 10 years
Min: -144.56, Med: -47.26, Max: 19.46
Current: 19.46
-144.56
19.46
Net Margin % 17.01
Net Margin range over the past 10 years
Min: -174.97, Med: -58.66, Max: 17.01
Current: 17.01
-174.97
17.01
ROE % 10.70
ROE range over the past 10 years
Min: -117.78, Med: -41.32, Max: 11
Current: 10.7
-117.78
11
ROA % 10.60
ROA range over the past 10 years
Min: -221, Med: -50.49, Max: 11.34
Current: 10.6
-221
11.34
ROC (Joel Greenblatt) % 75.80
ROC (Joel Greenblatt) range over the past 10 years
Min: -491.3, Med: -150.83, Max: 75.8
Current: 75.8
-491.3
75.8
3-Year Total Revenue Growth Rate 45.20
3-Year Revenue Growth Rate range over the past 10 years
Min: -49.5, Med: 3.6, Max: 416.2
Current: 19.9
-49.5
416.2

» BLFS's 30-Y Financials

Financials (Next Earnings Date: 2019-08-09)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:BLFS

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Instruments & Equipment » Medical Instruments & Equipment    NAICS : 339113    SIC : 3841
Compare NAS:SIEN SZSE:002432 AMEX:TRXC SZSE:300246 MIL:SFL XKRX:041830 NAS:UTMD NAS:PLSE SZSE:300453 TSE:7743 OSTO:SEDANA XSWX:VBSN SZSE:300030 HKSE:00801 XKRX:119610 SHSE:603880 BOM:531768 XMAD:PRM NAS:APYX TSE:4218
Traded in other countries BJX1.Germany
Address 3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.

Ratios

Current vs industry vs history
PE Ratio (TTM) 109.54
PE Ratio range over the past 10 years
Min: 73.08, Med: 111.6, Max: 529.75
Current: 109.54
73.08
529.75
Forward PE Ratio 109.89
N/A
PE Ratio without NRI 109.54
PE without NRI range over the past 10 years
Min: 73.08, Med: 111.6, Max: 529.75
Current: 109.54
73.08
529.75
PB Ratio 9.60
PB Ratio range over the past 10 years
Min: 1.68, Med: 3.96, Max: 20.89
Current: 9.6
1.68
20.89
PS Ratio 18.46
PS Ratio range over the past 10 years
Min: 0.76, Med: 3.36, Max: 26.08
Current: 18.46
0.76
26.08
Price-to-Free-Cash-Flow 162.29
Price-to-Free-Cash-Flow range over the past 10 years
Min: 69.32, Med: 159.7, Max: 3500
Current: 162.29
69.32
3500
Price-to-Operating-Cash-Flow 130.86
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 18.38, Med: 106.4, Max: 372.34
Current: 130.86
18.38
372.34
EV-to-EBIT 85.75
EV-to-EBIT range over the past 10 years
Min: -266.1, Med: -5.3, Max: 1870.2
Current: 85.75
-266.1
1870.2
EV-to-EBITDA 79.06
EV-to-EBITDA range over the past 10 years
Min: -785.5, Med: -5.5, Max: 850.1
Current: 79.06
-785.5
850.1
EV-to-Revenue 14.59
EV-to-Revenue range over the past 10 years
Min: -0.2, Med: 4.5, Max: 33.5
Current: 14.59
-0.2
33.5
Current Ratio 14.50
Current Ratio range over the past 10 years
Min: 0.09, Med: 2.16, Max: 55
Current: 14.5
0.09
55
Quick Ratio 12.99
Quick Ratio range over the past 10 years
Min: 0.04, Med: 1.47, Max: 55
Current: 12.99
0.04
55
Days Inventory 162.16
Days Inventory range over the past 10 years
Min: 37.89, Med: 138.57, Max: 193.93
Current: 162.16
37.89
193.93
Days Sales Outstanding 49.24
Days Sales Outstanding range over the past 10 years
Min: 33.81, Med: 53.08, Max: 72.68
Current: 49.24
33.81
72.68
Days Payable 70.98
Days Payable range over the past 10 years
Min: 34.86, Med: 65.49, Max: 142.54
Current: 70.98
34.86
142.54

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -20.20
3-Year Share Buyback Rate range over the past 10 years
Min: -77.4, Med: -0.3, Max: 28.4
Current: -20.2
-77.4
28.4

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 9.63
Price-to-Tangible-Book range over the past 10 years
Min: 0.97, Med: 5.05, Max: 49.35
Current: 9.63
0.97
49.35
Price-to-Projected-FCF 26.97
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 21.48, Med: 27.52, Max: 31.25
Current: 26.97
21.48
31.25
Price-to-Median-PS-Value 5.50
Price-to-Median-PS-Value range over the past 10 years
Min: 0.38, Med: 0.94, Max: 11.13
Current: 5.5
0.38
11.13
Price-to-Graham-Number 6.85
Price-to-Graham-Number range over the past 10 years
Min: 5.19, Med: 6.99, Max: 11.9
Current: 6.85
5.19
11.9
Earnings Yield (Joel Greenblatt) % 1.16
Earnings Yield (Greenblatt) range over the past 10 years
Min: -1126.4, Med: -15.7, Max: 2881.8
Current: 1.16
-1126.4
2881.8

More Statistics

Revenue (TTM) (Mil) $ 21.7
EPS (TTM) $ 0.16
Beta 1.72
Volatility % 91.77
52-Week Range $ 9.15 - 26.35
Shares Outstanding (Mil) 19.9

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 6
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA N
Lower Leverage yoy N
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y